Toggle light / dark theme

The robot, which weighs 420lbs, stands at 5ft 4in and travels at 3 miles per hour, is expected to make its appearance at the airport in the next two months, according to local reports.

According to Knightscope, the K5 is intended for outdoor use and features autonomous recharging without requiring human intervention. Features listed on Knightscope’s website include 360-degree and eye-level video streaming, people detection during certain restricted hours, thermal anomaly detection, as well as license plate recognition.

The city’s director of airports, Jesus Saenz, said that the K5 will be used to respond to door alarms at the airport and will be placed near doors with alarms that are frequently set off.

Discussions are emerging about conducting clinical trials on humans with nanorobots for medical applications. Currently, in the United States, four burgeoning companies are striving towards this aim, working to advance their nanomachines into Phase 1 studies, subsequent to laboratory research and preclinical trials on animals.

The article “Delivering drugs with microrobots”, published in Science on December 7, 2023, has recaptured the international scientific community’s attention on the practical, effective use of nanorobots in Clinical Practice and Medicine.

Its author, Bradley Nelson, a Robotics and Intelligent Systems professor at ETH Zurich, poses a straightforward question: where are these diminutive biocompatible machines, designed to be injected into the human body for more efficient exploration, internal repair, and precise, targeted drug delivery? Researchers have discussed them for years – he notes – yet we still do not see them progressing from laboratories to the forefront of clinical trials. How close are we to this milestone?